Our top pick for
Sigma Labs Inc is an information technology services business based in the US. Sigma Labs shares (SGLB) are listed on the NASDAQ and all prices are listed in US Dollars. Sigma Labs employs 20 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$3.11|
|52-week range||$2.02 - $6.74|
|50-day moving average||$3.33|
|200-day moving average||$3.52|
|Wall St. target price||$6.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.76|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-20)||-11.40%|
|1 month (2021-09-28)||-3.12%|
|3 months (2021-07-28)||-4.31%|
|6 months (2021-04-28)||-17.72%|
|1 year (2020-10-27)||33.48%|
|2 years (2019-10-25)||503.88%|
|3 years (2018-10-26)||104.61%|
|5 years (2016-10-27)||21.96%|
|Revenue TTM||$1.5 million|
|Gross profit TTM||$215,531|
|Return on assets TTM||-37.62%|
|Return on equity TTM||-61.72%|
|Market capitalisation||$34.1 million|
TTM: trailing 12 months
There are currently 586,836 Sigma Labs shares held short by investors – that's known as Sigma Labs's "short interest". This figure is 31.5% down from 856,223 last month.
There are a few different ways that this level of interest in shorting Sigma Labs shares can be evaluated.
Sigma Labs's "short interest ratio" (SIR) is the quantity of Sigma Labs shares currently shorted divided by the average quantity of Sigma Labs shares traded daily (recently around 96360.591133005). Sigma Labs's SIR currently stands at 6.09. In other words for every 100,000 Sigma Labs shares traded daily on the market, roughly 6090 shares are currently held short.
However Sigma Labs's short interest can also be evaluated against the total number of Sigma Labs shares, or, against the total number of tradable Sigma Labs shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Sigma Labs's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Sigma Labs shares in existence, roughly 60 shares are currently held short) or 0.0562% of the tradable shares (for every 100,000 tradable Sigma Labs shares, roughly 56 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Sigma Labs.
Find out more about how you can short Sigma Labs stock.
We're not expecting Sigma Labs to pay a dividend over the next 12 months.
Sigma Labs's shares were split on a 1:2 basis on 14 February 2017. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Sigma Labs shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for Sigma Labs shares which in turn could have impacted Sigma Labs's share price.
Over the last 12 months, Sigma Labs's shares have ranged in value from as little as $2.0158 up to $6.74. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sigma Labs's is 1.4386. This would suggest that Sigma Labs's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Sigma Labs, Inc. , a software company, provides in-process quality assurance software to the additive manufacturing industry under the PrintRite3D brand. It also offers PrintRite3D Lite, which has a smaller footprint and is geared towards single-laser machines for research and development, or small production lots; PrintRite3D Pro, for single, dual and quad laser machines and for environments with less than 10 machines; PrintRite3D Enterprise for plant-wide networks; and PrintRite3D for Direct Energy Deposition is based on a laser process in which a laser beam generates a melt pool on a substrate. The company also provides PrintRite3D-enabled engineering consulting services. It serves aerospace, defense, oil and gas, bio-medical, and power generation industries. The company was formerly known as Framewaves Inc. and changed its name to Sigma Labs, Inc.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.